You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 16, 2024

Details for Patent: 10,745,343

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 10,745,343 protect, and when does it expire?

Patent 10,745,343 protects ORSERDU and is included in one NDA.

This patent has nineteen patent family members in nine countries.

Summary for Patent: 10,745,343

Title:	Polymorphic forms of RAD1901-2HCl
Abstract:	Various polymorphic forms of RAD1901-2HCl, including three crystalline and amorphous forms, are prepared and characterized. Uses of the various polymorphic forms of RAD1901-2HCl for cancer treatment are also disclosed.
Inventor(s):	Cruskie, Jr. Michael Paul, Bolger Joshua Kyle, McKenzie Jonathan Blake, Sheth Pratik, Edwards Richard, Eberlin Alex, Markey Michael
Assignee:	RADIUS PHARMACEUTICALS, INC.
Application Number:	US16456314
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 10,745,343

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Stemline Therap	ORSERDU	elacestrant dihydrochloride	TABLET;ORAL	217639-001	Jan 27, 2023		RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial				TREATMENT OF AN ER-POSITIVE BREAST CANCER	⤷ Try a Trial
Stemline Therap	ORSERDU	elacestrant dihydrochloride	TABLET;ORAL	217639-002	Jan 27, 2023		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				TREATMENT OF AN ER-POSITIVE BREAST CANCER	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 10,745,343

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2018205285	⤷ Try a Trial
Australia	2023202085	⤷ Try a Trial
Canada	3047411	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.